- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 52.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 52.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 51.7M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $5M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $5M |
| Capex | Q1 2026 · Mar 31, 2026 | $26M |
| Capex | Q1 2026 · Mar 31, 2025 | $20M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $119M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $34M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.43B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.47B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $411M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $412M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.48B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.46B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $4.11B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $1.54B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.66B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.62B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.68B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.58B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.16B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.19B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.86 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$3.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.86 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$3.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $261M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $325M |
| Net Income | Q1 2026 · Mar 31, 2026 | $45M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$173M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $68M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$33M |
| Revenue | Q1 2026 · Mar 31, 2026 | $936M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $854M |